Skip to content

Ticagrelor Impurity 7

Ticagrelor Impurity 7

Product Description
CAT No.
ALN-T023125
CAS No.
NA
Mol. F.
C10H19NO4 : C4H6O6
Mol. Wt.
217.27 : 150.1
Stock
Please Inquire
Chemical Name : (R)-1-(((3aS,4R,6S,6aR)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol (2R)-2,3-dihydroxysuccinate
Smiles : C[C@H](O)O[C@@H]1C[C@H](N)[C@]2([H])[C@@]1([H])OC(C)(C)O2.O=C(O)C(O)[C@@H](O)C(O)=O
Inchi : InChI=1S/C27H38O4/c1-26-13-11-18(28)15-22(26)23(29)16-19-20-8-9-24(27(20,2)14-12-21(19)26)31-25(30)10-7-17-5-3-4-6-17/h15,17,19-21,24H,3-14,16H2,1-2H3/t19?,20?,21?,24?,26-,27+/m1/s1

Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method

By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.

Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies

By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724

Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)

By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42

Request For Quotation